Form4insider filings, from the source

SEC Form 4 · accession 0001127602-18-014223

UNITED THERAPEUTICS Corp · UTHR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Martine A Rothblatt
Officer — Chairman & CEO · Director
Period of report
Apr 4, 2018
Accepted (ET)
Apr 6, 2018 · 4:03 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001082554

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockApr 4, 2018M21,512$52.65A21,652D
Common StockF2Apr 4, 2018S3,200$113.5157D18,452D
Common StockF3Apr 4, 2018S6,181$114.5857D12,271D
Common StockF4Apr 4, 2018S10,449$115.3109D1,822D
Common StockF5Apr 4, 2018S1,682$116.2941D140D
Common StockApr 5, 2018M21,512$52.65A21,652D
Common StockF6Apr 5, 2018S12,507$113.0868D9,145D
Common StockF7Apr 5, 2018S2,739$113.8155D6,406D
Common StockF8Apr 5, 2018S1,400$115.0682D5,006D
Common StockF9Apr 5, 2018S870$116.4906D4,136D
Common StockF10Apr 5, 2018S1,994$117.2458D2,142D
Common StockF11Apr 5, 2018S1,602$117.9632D540D
Common StockF12Apr 5, 2018S400$118.8625D140D
Common Stockholding———683,489IBy Trusts

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Options$52.65Apr 4, 2018M21,512DDec 31, 2009Dec 31, 2019Common Stock21,512212,675D
Stock Options$52.65Apr 5, 2018M21,512DDec 31, 2009Dec 31, 2019Common Stock21,512191,163D

Explanation of responses